well said NW, the resource part of the story has only improved and the report on Jan 29th, hi lighted the potential for the Yield to improve 20+%, to an already impressive resource, and to potentially reduce the ROM volumes should have a huge impact on the cost of production, which in turn improves an already impressive figures well documented, but these results have had little bearing on the SP, it seems to have gone under the radar.
As you said, it hit $2.10 on the back of the original story, and although things have not gone to plan,
(most if not all attributed to the former directors i believe), once BSP is approved, it is the catalyst for everything to then move forward. Off Take partners should fill the cash position, as they have always stated, and if there seems to be a supply issue now or coming, then i would hope BB and board take what ever time is necessary to achieve the best deal for ATU, which is the best deal for all SH
I can only imagine taking a Junior explorer to small mine and ultimately major mine producer has its setbacks for all companies that have come before ATU and succeeded, they as well would have had delays as well. I also believe the continued encouraging drill results from the greater GHNMC and Panaroma fields, as well as the self inflicted damage you refer to, would make it hard for ATU to make, or want to make, any sort of rash Anns until they are 100% certain they wont be undermined by forces outside of their control, which is the only reason we are where we are today
in saying that, every-time there is a seller, someone is buying.
- Forums
- ASX - By Stock
- ATU
- Broker Note
Broker Note, page-2
-
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATU (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.25M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
ATU (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online